Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Amur Minerals ( (GB:CRTX) ) has provided an announcement.
CRISM Therapeutics Corporation announced the successful completion of a Retail Offer and an Additional Placing, raising a total of £874,021. The funds will support the development of ChemoSeed, including GMP manufacturing and clinical trials, positioning the company to advance its innovative cancer treatment technology.
More about Amur Minerals
CRISM Therapeutics Corporation is a company that has developed an innovative drug delivery technology aimed at improving the clinical performance of cancer treatments for solid tumors. Their lead product, ChemoSeed, is designed to deliver chemotherapy drugs directly into tumors or resection margins, enhancing treatment efficacy by bypassing barriers such as the blood-brain barrier in cases like high-grade glioma.
Average Trading Volume: 85,459
Technical Sentiment Signal: Sell
Current Market Cap: £1M
See more data about CRTX stock on TipRanks’ Stock Analysis page.